Actionable news
All posts from Actionable news
Actionable news in DVAX: Dynavax Technologies Corporation,

Perilous Reversal Stock: Dynavax Technologies (DVAX)

Trade-Ideas LLC identified Dynavax Technologies ( DVAX) as a "perilous reversal" (up big yesterday but down big today) candidate. In addition to specific proprietary factors, Trade-Ideas identified Dynavax Technologies as such a stock due to the following factors:

  • DVAX has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $19.6 million.
  • DVAX has traded 79,263 shares today.
  • DVAX is down 3.3% today.
  • DVAX was up 7% yesterday.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in DVAX with the Ticky from Trade-Ideas. See the FREE profile for DVAX NOW at Trade-Ideas More details on DVAX: Dynavax Technologies Corporation, a clinical-stage biopharmaceutical company, discovers and develops novel vaccines and therapeutics in the United States. Its development programs focuses on vaccine adjuvants, cancer immunotherapy, and autoimmune and inflammatory diseases. Currently there are 2 analysts that rate Dynavax Technologies a buy, no analysts rate it a sell, and 2 rate it a hold. The average volume for Dynavax Technologies has been 950,200 shares per day over the past 30 days. Dynavax has a market...